1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends

Trends and Innovations in Key Account Management

  • By Firstword Pharma
  • Report Number: 3153883

Summary

Table of Contents




Your customers need and demand more from you today. Key Account Management (KAM) is the model designed to deliver it. But as prescribing decisions become increasingly complicated, complexity that is compounded by the growth of integrated care networks, how can KAM meet the challenges that lie ahead?

Trends and Innovations in Key Account Management provides anyone involved in developing, implementing or delivering KAM with a comprehensive understanding of the issues shaping the KAM landscape and the critical factors that determine its success. The report sets out an approach for the optimal KAM function with insights from leading experts and those running successful KAM operations.







Key Issues Explored

Get insights from leading pharma companies and experts on key issues that help you answer critical questions

What is good KAM practice?
What factors are critical to the success of a KAM program?
How has the shift of prescribing power to integrated decision-making groups fuelled the growth of KAM?
What is the importance of cross-functional buy-in to the success of KAM?
How can KAM as a strategy facilitate market access?
How do you identify the key attributes key account managers must possess?
What tools and tactics are critical to implementing a KAM strategy?
What is KAM’s role in the pursuit of true customer-centricity?
What are the barriers faced by companies implementing KAM?
What are the key strategies to ensure successful implementation of KAM?
How will KAM need to evolve over the next 5 years?



Top Takeaways

Learn the top ten critical success factors for successful implementation of a KAM approach
Determine which customers merit a KAM approach
Identify, segment and prioritise customers for the optimal approach to KAM
Build mutually beneficial partnerships with customers for long-term value creation
Understand how KAMs facilitate the building of strong partnerships with payers for market access gains
Understand strategies, tools and tactics for the implementation of a successful KAM program




About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence



FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you get this report now

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Biosimilars Market Access in the U.S.

  • $ 7500
  • Industry report
  • March 2017
  • by Datamonitor Healthcare

The route to a formal US regulatory pathway for biosimilar approval was established with the creation of the Biologics Price Competition and Innovation Act of 2010. However, it took five more years fo ...

Biosimilars Market Access in Psoriasis

  • $ 7500
  • Industry report
  • March 2017
  • by Datamonitor Healthcare

Tumor necrosis factor (TNF)-alpha inhibitors Enbrel, Humira, and Remicade have long held dominant positions in the psoriasis market; however, these market leaders face patent expirations and consequent ...

Global Markets for Protein Labeling

  • $ 6650
  • Industry report
  • February 2017
  • by BCC Research

Use this report to: - Identify key market dynamics and the factors impacting the global protein-labeling market and its subsegments. - Gain insight into global protein-labeling market and its market segments, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.